Malaria Treatment Market

Contents

Executive Summary

Global Malaria Treatment Market
Product Overview
Market Definition
Segmentation
Assumptions and Acronyms
Research Methodology
Research Objectives
Primary Research
Secondary Research
Forecast Model
Market Size Estimation
Average Pricing Analysis
Macro-Economic Indicators

Market Dynamics
Growth Drivers
Restraints
Opportunities
Trends

Correlation & Regression Analysis
Correlation Matrix
Regression Matrix

Recent Developments, Policies & Regulatory Landscape

Risk Analysis
Demand Risk Analysis
Supply Risk Analysis

Global Malaria Treatment Market Analysis
Porter’s Five Forces Analysis
Threat of New Entrants
Bargaining Power of Suppliers
Threat of Substitutes
Rivalry among Competitors
PEST Analysis
Political
Economic
Social
Technological

Global Malaria Treatment Market
Market Size & Forecast, 2020A–2031F
By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

Global Malaria Treatment Market: Market Segmentation

By Drug Class
Artemisinin-Based Combination Therapies (ACTs), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Chloroquine Phosphate, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Vaccines, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By Drug Type
Mefloquine, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Primaquine Phosphate, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Quinine Sulfate, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Artemether & Lumefantrine, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Mosquirix, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By Treatment Type
Vaccination, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Medication, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Supportive Care, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By Route of Administration
Parenteral, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Oral, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By Distribution Channel
Hospital Pharmacies, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Retail Pharmacies, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Online Pharmacies, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By End-User
Hospitals, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Specialty Clinics, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Homecare, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Others, By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

By Region
North America: (U.S. and Canada), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Asia-Pacific: (India, China, Japan, South Korea, Malaysia, Indonesia, Australia, New Zealand, Rest of Asia-Pacific), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F
Middle East & Africa: (North Africa, Israel, GCC, South Africa, Rest of Middle East & Africa), By Value (USD Million) 2020–2031F; Y-o-Y Growth (%) 2021–2031F

Company Profiles
Pfizer Inc.
Novartis AG
Amayris
GlaxoSmithKline
Lannett Company Inc.
Concordia International Corp.
Teva Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc.
Baxter International Inc.
Sanofi
Other Prominent Players

Consultant Recommendations

The above segmentations and company profiles are subject to further modification based on detailed feasibility analysis conducted for the final report deliverable.